PLATELET-ACTIVATING-FACTOR AND CELLULAR IMMUNE-RESPONSES

[11] LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) : 1356 - +

[12] PLATELET-ACTIVATING FACTOR, A NEW MEDIATOR OF ANAPHYLAXIS AND IMMUNE-COMPLEX DEPOSITION FROM RABBIT AND HUMAN BASOPHILS [J]. NATURE, 1974, 249 (5457) : 581 - 582

[13] ANTI-NEOPLASTIC ACTIVITY OF SYNTHETIC LYSOPHOSPHOLIPID ANALOGS [J]. BLUT, 1982, 44 (02): : 71 - 78

[14] BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41

[15] PAF-ACETHER AND LEUKOTRIENE PARTICIPATION IN ACUTE CIRCULATORY SHOCK [J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 : 139 - 150

[16] BETZ SJ, 1980, J IMMUNOL, V125, P2756

[17] THE EFFECT OF 1-O-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (PAF-ACETHER) ON THE ARTERIAL-WALL [J]. PROSTAGLANDINS, 1985, 30 (02): : 185 - 197

[18] BOURGAIN RH, UNPUB NATURE

[19] BRAQUET P, 1987, PHARMACOL REV, V39, P97

[20] PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) : 397 - 403

[11] LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) : 1356 - +

[12] PLATELET-ACTIVATING FACTOR, A NEW MEDIATOR OF ANAPHYLAXIS AND IMMUNE-COMPLEX DEPOSITION FROM RABBIT AND HUMAN BASOPHILS [J]. NATURE, 1974, 249 (5457) : 581 - 582

[13] ANTI-NEOPLASTIC ACTIVITY OF SYNTHETIC LYSOPHOSPHOLIPID ANALOGS [J]. BLUT, 1982, 44 (02): : 71 - 78

[14] BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41

[15] PAF-ACETHER AND LEUKOTRIENE PARTICIPATION IN ACUTE CIRCULATORY SHOCK [J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 : 139 - 150

[16] BETZ SJ, 1980, J IMMUNOL, V125, P2756

[17] THE EFFECT OF 1-O-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (PAF-ACETHER) ON THE ARTERIAL-WALL [J]. PROSTAGLANDINS, 1985, 30 (02): : 185 - 197

[18] BOURGAIN RH, UNPUB NATURE

[19] BRAQUET P, 1987, PHARMACOL REV, V39, P97

[20] PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (10) : 397 - 403